Brief: Cyclo Therapeutics Says It Received A Notice From Nasdaq Informing That Company Is In Compliance With All Applicable Nasdaq Listing Standards
22/01/2024 11:58
Jan 22 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS - ON JAN 17 RECEIVED A NOTICE FROM
NASDAQ
INFORMING THAT CO IS IN COMPLIANCE WITH ALL APPLICABLE NASDAQ
LISTING STANDARDS
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug